Ownership history in Bayesian Capital Management, LP · 18 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in ZIMMER BIOMET HLDGS INC (ZBH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 12,500 | -14,107 | -53.0% | 0.25% | $1.2M | $98.24 |
| 2024 Q4 | ADDED | 26,607 | +22,900 | +617.8% | 0.34% | $2.8M | $104.60 |
| 2024 Q3 | REDUCED | 3,707 | -16,993 | -82.1% | 0.05% | $400K | $106.65 |
| 2023 Q2 | ADDED | 20,700 | +7,400 | +55.6% | 0.32% | $3.0M | $142.35 |
| 2023 Q1 | ADDED | 13,300 | +6,226 | +88.0% | 0.21% | $1.7M | $126.11 |
| 2022 Q4 | REDUCED | 7,074 | -2,285 | -24.4% | 0.13% | $902K | $124.21 |
| 2022 Q2 | ADDED | 9,359 | +3,471 | +59.0% | 0.18% | $983K | $101.93 |
| 2021 Q2 | ADDED | 5,888 | +2,788 | +89.9% | 0.25% | $947K | $150.33 |
| 2020 Q3 | REDUCED | 3,100 | -2,400 | -43.6% | 0.10% | $422K | $126.67 |
| 2020 Q2 | REDUCED | 5,500 | -6,000 | -52.2% | 0.14% | $656K | $110.86 |
As of 2025 Q4 — sorted by position size